Benjamin Doranz, PhD, MBA

President & CEO at Integral Molecular

Ben Doranz is President and CEO of Integral Molecular. Dr. Doranz co-founded the company in 2001 and has led all aspects of the company’s growth since its inception, bringing five different technologies from research to market.

He is an inventor on six of the company’s patents, the principal investigator on over 30 NIH grants, and an author on over 90 publications, including articles published in Cell, Science, and Nature. Dr. Doranz earned a Ph.D. in Cellular and Molecular Biology from the University of Pennsylvania and an MBA from Wharton.


Lessons in Discovering Antibodies against GPCRs, Ion Channels, and Transporters